Auburn University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Auburn University sits in the top decile of US sponsors by registered trial count (#351 of 15,742 sponsors by registered trial count).
Auburn University: 54 sponsored US clinical trials, 13 recruiting.
Auburn University sponsors 54 registered US clinical trials on ClinicalTrials.gov, 13 of them currently recruiting, and 31 completed. 0 of these trials are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Eating Disorder Symptom, with 2 trials.
Top-decile sponsor footprint
Auburn University ranks in the top decile of sponsors by registered trial count (#351 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
31 of 33 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (93.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
54 total, page 1 of 2
Cannabis and Processing Emotions Study
NCT06907979
A Combined Neurofeedback-TMS Intervention for Alcohol Use Disorder
NCT05621538
Using TMS to Understand Neural Processes of Social Motivation
NCT06274112
Digital Intervention for Physical Activity
NCT07130734
Forge AHEAD: Feasibility of Yoga to Improve Cognitive Function
NCT07489105
Targeting Minority Stressors to Improve Eating Disorder Symptoms in Sexual Minority Individuals With Eating Disorders
NCT06565637
A Single-Arm Pilot Trial for Mitigating Relapse of Severe Problem Behavior
NCT06732219
Potassium, Hydration, Cardiovascular, and Kidney Study (PHACKs)
NCT06062017
Optimizing Dimensions of Reinforcement
NCT07137273
Curcumin and EGCG Supplementation to Improve Serum BDNF and Mood Disturbance
NCT06531863
Influence of TMS on Attention Modulation
NCT05611502
Pilot of Reconnecting to Internal Sensations and Experiences in Undergraduates
NCT05285111
The Influence of Mitochondrial-Derived Reactive Oxygen Species on Racial Disparities in Neurovascular Function
NCT04334135
Greens-Based Crossover Trial to Improve Epigenetic Aging in Adults
NCT06537232
Testing the Effects of RISE on Eating Pathology
NCT05837312
Good Nights Sleep Program to Improve Child and Family Sleep
NCT06249217
Improving Metabolic & Mental Health in Female Healthcare Shift Workers
NCT06158204
Sleep and Vascular Health Study
NCT05918744
Brief Single-Session Body Neutrality Program for LGBTQ+ Adults in Central Alabama
NCT07621081
Interacting With Children Training for Undergraduates
NCT07696611
Multimodal Immune and Neuroendocrine Assessment in Drinkers
NCT07220148
Effects of Carbohydrates Versus Carbohydrates + Protein on Resistance Training Outcomes
NCT07600138
Double Crossover Casein Type Tolerance Trial
NCT06315517
Writing Wrongs: Expressive Writing for Microaggressions
NCT06276725
First-generation OTC Antihistamine Use and Voice Function: A Preliminary Study
NCT05858216
Mitochondria Oxidative Stress and Vascular Health Study
NCT05561556
Text Message and Competition-Based Interventions Among University Students
NCT06246812
Evaluating Body Acceptance Programs for Young Men
NCT05258409
Safety of Co-Administered CHI-554 and Alcohol
NCT05317507
Whole Coffee Cherry Study
NCT04986956
Active Play Intervention for Preschoolers
NCT05744791
Peanut Protein Supplementation to Prevent Muscle Atrophy and Improve Recovery Following Total Knee Arthroplasty
NCT04294563
Anti-anxiety Biotics for Breast Cancer Survivors
NCT04784182
Motivational Interviewing & Clinician Centered Interviewing on Cardiac Rehab
NCT04899752
Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Young Adults
NCT04707963
The Effects of Virtual Zumba® in Individuals With Developmental Disabilities
NCT05198232
A Single-Session Online Insomnia Intervention
NCT04988464
Multimodal Neuroimaging of Alcohol Cues, Cortisol Response, and Compulsive Motivation
NCT04412824
"Neighborhood Disadvantage, Sleep and Vascular Health"
NCT04576338
Motivational Interviewing to Address Freshman Weight Gain
NCT04130386
Effects of Framing on Medication Beliefs, Intentions to Take Medication, Adherence, and Asthma Control
NCT06033313
Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Older Adults
NCT04015479
Auburn University Research on Olive Oil for Alzheimer's Disease (AU-ROOAD)
NCT03824197
Effect of Interval and Resistance Exercise on Physiological and Psychological Parameters.
NCT04751240
Assessing Barriers and Increasing Use of Immunization Registries in Pharmacies
NCT03796585
A Pharmacist-led Transitions of Care Program
NCT04556786
Preventing Opioid Overdose Deaths by Empowering Pharmacists to Dispense Naloxone
NCT05093309
Exploring the Effects of a High Chlorophyll Dietary Intervention to Reduce Colon Cancer Risk in Adults
NCT03582306
The Effects of a Multi-vitamin Supplement in Adult Females
NCT03828097
Increasing Children's Defending Behaviors: Using Deviance Regulation
NCT04681209
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
Therapeutic Areas
What is open in the Auburn University pipeline
13 recruiting of 54 indexed (24% open); 31 completed (57%).
Phase mix: 0 late (III/IV) vs 6 early (I/II) (early-phase heavy).
Top condition: Eating Disorder Symptom (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Auburn University: open-pipeline peers nationwide
Peers matched on 54 registered trials and 24% open enrollment, not the therapeutic-area sidebar.
Auburn University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 54 trials (± recruiting share)
- AdventHealth Translational Research Institute · 54 trials · 24% recruiting
- Brooke Army Medical Center · 54 trials · 11% recruiting
- Corcept Therapeutics · 54 trials · 11% recruiting
- Pharmacyclics · 54 trials · 0% recruiting
Sponsors near 24% open enrollment (± trial volume)
- Center for International Blood and Marrow Transplant Research · 24% recruiting · 29 trials
- Boston Children's Hospital · 24% recruiting · 462 trials
- Genmab · 24% recruiting · 45 trials
- Chugai Pharmaceutical · 24% recruiting · 17 trials
Related
What to do with this Auburn University page
54 registered trials is a research-attention snapshot, not an endorsement of Auburn University or any single study.
- 13 of Auburn University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Eating Disorder Symptom is the condition Auburn University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Eating Disorder Symptom trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Auburn University pipeline card: 54 registered trials from official public datasets.Report a data error.